Smita Bhatia

26PUBLICATIONS
143CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 09, 2026
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.

|Mar 03, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Tessa F Flores, Emily S Tonorezos, Shailender Bhatia

|Jan 16, 2026
Steroid-sparing strategies for managing immune-related adverse events.

Jennifer J Huang, Maryam YousefiAsl, Namrata Singh

|Jan 10, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Juan Alban, R Christopher Bowen, David A Reichstein

|Dec 25, 2025
Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanoma.

Melissa M Yamada, Smitha Chandrasekhar, Ted A Gooley

|Sep 19, 2025
Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials.

Peter Y Ch'en, Yuzheng Zhang, Daniel S Hippe

Pageof 5

Frequent Collaborators

12 joint publications

Paul T Nghiem

6 joint publications

Tomoko Akaike

4 joint publications

Lisa Tachiki

4 joint publications

Song Youn Park